Pharma & Biotech

IQ Biozoom Innovates Non-Invasive Self-Testing, Empowering People to Self-Monitor with Laboratory Precision at Home

(IN BRIEF) IQ Biozoom, a medical technology startup, is developing non-invasive home diagnostics that allow people to measure the concentration…

2 years ago

Kuehne+Nagel’s Rapid Response Delivers Flu Vaccines to 42 Veterans Affairs Hospitals Across the U.S.

(IN BRIEF) Kuehne+Nagel's North American Road Logistics team received an urgent request from a pharmaceutical customer to deliver 150 pallets…

2 years ago

AstraZeneca’s Imfinzi Combination Therapy Shows Promise in Phase III Trial for Liver Cancer Treatment

(IN BRIEF) AstraZeneca has reported positive high-level results from the EMERALD-1 Phase III trial, demonstrating that its drug Imfinzi (durvalumab),…

2 years ago

AstraZeneca Secures Exclusive License for ECC5004, Promising Oral GLP-1RA for Cardiometabolic Conditions

(IN BRIEF) AstraZeneca and Eccogene have signed an exclusive license agreement for ECC5004, an investigational oral once-daily glucagon-like peptide 1…

2 years ago

Roche’s Elecsys NfL Test for Multiple Sclerosis Earns Breakthrough Device Designation from FDA

(IN BRIEF) Roche, a leading healthcare company, has announced that its Elecsys Neurofilament Light Chain (NfL) test for Multiple Sclerosis…

2 years ago

Chr. Hansen’s Probiotic Strain DDS-1® Authorized by Health Canada for Stress Relief in IBS

(IN BRIEF) Health Canada has granted authorization for the probiotic strain Lactobacillus acidophilus DDS-1® to make health claims related to…

2 years ago

Late-Stage Parkinson’s Patients Find New Hope in Treatment Changes, TUM Study Shows

(IN BRIEF) A recent study led by the Technical University of Munich (TUM) reveals that late-stage Parkinson's disease patients may…

2 years ago